Genomic Medicine: Why Do "Similar" Patients Have Different Outcomes?

Overview

Journal Rev Course Lect

Specialty Anesthesiology

Date 2016 Jan 8

PMID 26740973

Authors

Debra Schwinn

Maren Kleine-Brueggeney

Anush Oganesian

Affiliations

Soon will be listed here.

Abstract

Genomic variation is an important factor in why supposedly "similar" patients react differently to drugs, have different disease course(s), and varying clinical outcomes. This review provides an update on concepts in modern genomic medicine with an emphasis on clinically relevant study approaches, disease/drug pathway analysis, and recent pharmacogenomic findings. The application of genomic medicine and its importance for rapid diagnosis of disease-causing agents, as well as its clinical application in human disease diagnosis/treatment and in cardiovascular disease are discussed. In addition to direct clinical applications, modern genomic approaches also play an important role in elucidating new mechanisms of disease. Finally, the role of the National Institutes of Health national pharmacogenomics research network in codifying "bench to bedside" translation of genetic results that impact drug therapy will also be discussed.

References

Lee Y, Kim M, Han J, Yeom K, Lee S, Baek S . MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004; 23(20):4051-60. PMC: 524334. DOI: 10.1038/sj.emboj.7600385. View

Foulkes W, Smith I, Reis-Filho J . Triple-negative breast cancer. N Engl J Med. 2010; 363(20):1938-48. DOI: 10.1056/NEJMra1001389. View

Josko D . Molecular bacteriology in the clinical laboratory. Clin Lab Sci. 2010; 23(4):237-41. View

Kurtz T . Genome-wide association studies will unlock the genetic basis of hypertension.: con side of the argument. Hypertension. 2010; 56(6):1021-5. DOI: 10.1161/HYPERTENSIONAHA.110.156190. View

Schickel R, Boyerinas B, Park S, Peter M . MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene. 2008; 27(45):5959-74. DOI: 10.1038/onc.2008.274. View

Burmester J, Berg R, Yale S, Rottscheit C, Glurich I, Schmelzer J . A randomized controlled trial of genotype-based Coumadin initiation. Genet Med. 2011; 13(6):509-18. DOI: 10.1097/GIM.0b013e31820ad77d. View

Bourne T, Schiff D . Update on molecular findings, management and outcome in low-grade gliomas. Nat Rev Neurol. 2010; 6(12):695-701. DOI: 10.1038/nrneurol.2010.159. View

Gladding P, Panattoni L, Webster M, Cho L, Ellis S . Clopidogrel pharmacogenomics: next steps: a clinical algorithm, gene-gene interactions, and an elusive outcomes trial. JACC Cardiovasc Interv. 2010; 3(10):995-1000. DOI: 10.1016/j.jcin.2010.08.012. View

Gentles A, Plevritis S, Majeti R, Alizadeh A . Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. JAMA. 2010; 304(24):2706-15. PMC: 4089862. DOI: 10.1001/jama.2010.1862. View

10.

Kruger B, Schroppel B . Genetic variations and transplant outcomes. Nephron Clin Pract. 2010; 118(1):c49-54. DOI: 10.1159/000320904. View

11.

St Hilaire C, Ziegler S, Markello T, Brusco A, Groden C, Gill F . NT5E mutations and arterial calcifications. N Engl J Med. 2011; 364(5):432-42. PMC: 3049958. DOI: 10.1056/NEJMoa0912923. View

12.

Voortman J, Goto A, Mendiboure J, Sohn J, Schetter A, Saito M . MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma. Cancer Res. 2010; 70(21):8288-98. PMC: 2970724. DOI: 10.1158/0008-5472.CAN-10-1348. View

13.

Goodman R, Freret T, Kula T, Geller A, Talkington M, Tang-Fernandez V . Clinical isolates of Trichomonas vaginalis concurrently infected by strains of up to four Trichomonasvirus species (Family Totiviridae). J Virol. 2011; 85(9):4258-70. PMC: 3126235. DOI: 10.1128/JVI.00220-11. View

14.

Hoffman H, Brydges S . Genetic and molecular basis of inflammasome-mediated disease. J Biol Chem. 2011; 286(13):10889-96. PMC: 3064144. DOI: 10.1074/jbc.R110.135491. View

15.

Naesens M, Sarwal M . Molecular diagnostics in transplantation. Nat Rev Nephrol. 2010; 6(10):614-28. DOI: 10.1038/nrneph.2010.113. View

16.

Pajic M, Murray J, Marshall G, Cole S, Norris M, Haber M . ABCC1 G2012T single nucleotide polymorphism is associated with patient outcome in primary neuroblastoma and altered stability of the ABCC1 gene transcript. Pharmacogenet Genomics. 2011; 21(5):270-9. DOI: 10.1097/FPC.0b013e328343dd5f. View

17.

Wang L, McLeod H, Weinshilboum R . Genomics and drug response. N Engl J Med. 2011; 364(12):1144-53. PMC: 3184612. DOI: 10.1056/NEJMra1010600. View

18.

Aaron S, Vandemheen K, Ramotar K, Giesbrecht-Lewis T, Tullis E, Freitag A . Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis. JAMA. 2010; 304(19):2145-53. DOI: 10.1001/jama.2010.1665. View

19.

Pham M, Teuteberg J, Kfoury A, Starling R, Deng M, Cappola T . Gene-expression profiling for rejection surveillance after cardiac transplantation. N Engl J Med. 2010; 362(20):1890-900. DOI: 10.1056/NEJMoa0912965. View

20.

Autelitano D, Woodcock E . Selective activation of alpha1A-adrenergic receptors in neonatal cardiac myocytes is sufficient to cause hypertrophy and differential regulation of alpha1-adrenergic receptor subtype mRNAs. J Mol Cell Cardiol. 1998; 30(8):1515-23. DOI: 10.1006/jmcc.1998.0717. View